{{item.title}}
{{item.text}}
{{item.title}}
{{item.text}}
ADQ, one of Abu Dhabi’s largest holding companies, will acquire 100% of Acino from its current shareholders, Nordic Capital and Avista Capital Partners.
Acino is a Swiss-based leading provider of pharmaceuticals with presence in more than 90 countries across the Middle East, Africa, Latin America, Russia, Ukraine and the CIS Region. The company is a leader in more than 20 therapeutic areas including gastroenterology, cardiovascular and pain relief for high-quality pharmaceutical products in novel drug delivery forms.
Acino will be ADQ’s largest acquisition in its healthcare and pharma portfolio.
The PwC Deals team supported Acino and its current shareholders with Financial Vendor Due Diligence and a Tax Fact Book.